Gilead acquiring synthetic CAR T company Cell Design

On Dec. 7, Gilead Sciences Inc. (NASDAQ:GILD) said it will acquire Cell Design Labs Inc. (San Francisco, Calif.) for $175 million up front, plus up to

Read the full 268 word article

User Sign In